van Bogaert, L, HJ Scherer, and E Epstein. :Une Forme Cérébrale de la Cholestérinose Généralisée: (Type Particulier de Lipidose á Cholestérine). ,Mason et Cie. ,Paris. ,1937. .
Lee, MH, S Hazard, JD Carpten, et al. :Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees. .J Lipid Res 42::159. ,2001. .
Bjorken, I, KM Boberg, and E Leitersdoef. : “Inborn Errors in Bile Acid Biosynthesis and Storage of Sterols Other than Cholesterol. ,” inThe Metabolic and Molecular Bases of I nherited Disease. , ed byScriver, CR and AL Beaudet. , p2970. ,McGraw-Hill. ,New York. ,2001. .
Federico, A and MT Dotti. :Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis and therapy. .J Child Neurol 18::633. ,2003. .
Gallus, GN, MT Dotti, and A Federico. :Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. .Neurol Sci 27::143. ,2006. .
Wolthers, BG, M Volmer, JC van der Molen, et al. :Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine, using capillary gas chromatography. .Clin Chim Acta 131::53. ,1983. .
Wolthers, BG, HT Walrecht, JC van der Molen, et al. :Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. .J Lipid Res 32::603. ,1991. .
Cruysberg, JR, RA Wevers, and JJ Tolboom. :Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. .Am J Ophthalmol 112::606. ,1991. .
Cruysberg, JR, RA Wevers, BG van Engelen, et al. :Ocular and systemic manifestations of cerebrotendinous xanthomatosis. .Am J Ophthalmol 120::597. ,1995. .
Kuritzky, A, VM Berginer, and AD Korczyn. :Peripheral neuropathy in cerebrotendinous xanthomatosis. .Neurology 29::880. ,1979. .
Katz, DA, L Scheinberg, DS Horoupian, et al. :Peripheral neuropathy in cerebrotendinous xanthomatosis. .Arch Neurol 42::1008. ,1985. .
Berginer, VM, S Shany, and D Alkalay. :Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. .Metabolism 42::69. ,1993. .
Chang, WN and CC Lui. :Failure in the treatment of longstanding osteoporosis in cerebrotendinous xanthomatosis. .J Formos Med Assoc 96::225. ,1997. .
Kuriyama, M, J Fujiyama, R Kubota, et al. :Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. .Metabolism 42::1497. ,1993. .
Moghadasain, MH . :Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. .Clin Invest Med 27::42. ,2004. .
Halperin, G, M Elisaf, E Leitersdorf, et al. :A new method for determination of serum cholestanol by high-performance liquid chromatography with ultraviolet detection. .J Chromatogr B 34::345. ,2000. .
Berginer, VM, G Salen, and S Shefer. :Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. .N Engl J Med 311::1649. ,1984. .
Mondelli, M, A Rossi, C Scarpini, et al. :Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid. .Arch Neurol 49::469. ,1992. .
Mondelli, M, A Rossi, C Scarpini, et al. :Cerebrotendinous xanthomatosis: 11 year treatment with chenodeoxycholic acid in five patients: an electrophysiological study. .J Neurol Sci 190::29. ,2001. .
Brodsky, JW, AD Beischer, D Anat, et al. :Cerebrotendinous xanthomatosis: a rare cause of bilateral Achilles tendon swelling and ataxia: a case report. .J Bone Joint Surg Am 88::1340. ,2006. .
Xanthomas are described as deposits in the skin and subcutaneous tissues. Mostly known as pseudotumors, xanthomas consist of connective tissue containing mainly cholesterol, triglycerides, and numerous foamy macrophages. Bilateral Achilles tendon xanthomata is pathognomonic for cerebrotendinous xanthomatosis in the case of normal cholesterol levels but increased cholestanol levels in serum. In this article, we present findings regarding bilateral xanthomas of Achilles tendons in a patient with cerebrotendinous xanthomatosis. (J Am Podiatr Med Assoc 103(2): 152–155, 2013)